Sarepta Therapeutics Inc.
SRPT | NASDAQ
$18.32
-$0.30 (-1.61%)
At close: Nov 2, 2026, 4:00 PM ET
$18.39
+$0.07 (+0.38%)
After-hours:
Nov 2, 2026, 4:44 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 571.15M | 464.45M | 801.28M | 613.08M | 510.6M | 240.87M | 1.1B | 197.86M | 383.62M | 427.29M | 428.43M | 541.93M | 851.93M | 871.67M | 966.78M | 1.04B | 868.57M | 1.23B | 2.12B | 1.6B | 1.7B | 1.48B |
Short-Term Investments | 217.34M | 188.74M | 138.37M | 237.92M | 289.54M | 281.9M | 251.78M | 1B | 1.08B | 963.45M | 1.25B | 1.19B | 1.01B | 1.01B | 1.02B | 1.03B | 1.06B | 779.55M | n/a | n/a | 30M | 256M |
Long-Term Investments | 145.37M | 102.86M | 1.05M | 9.21M | 34.6M | 109.13M | 136.87M | 186.49M | 7.61M | 41.38M | 6.53M | 7.5M | 31M | 31M | 31.32M | 33.24M | 33.23M | 33.39M | 34.89M | 44.6M | 49.29M | 49.96M |
Other Long-Term Assets | 341.87M | 271.71M | 311.15M | 231.86M | 442.81M | 389.88M | 237.3M | 253.82M | 304.56M | 313.64M | 291.99M | 286.04M | 194.98M | 288.33M | 286.62M | 259.88M | 250.97M | 245.26M | 258.06M | 146.19M | 154.27M | 161.63M |
Receivables | 482.61M | 547.91M | 519.61M | 541.6M | 609.6M | 724.52M | 649.73M | 515.99M | 392.26M | 419.38M | 436.98M | 354.26M | 267.16M | 288.08M | 261.6M | 223.45M | 230.28M | 197.2M | 172.75M | 181.56M | 148.26M | 136.37M |
Inventory | 904.27M | 1B | 914.74M | 1.08B | 994.04M | 941.43M | 749.96M | 565.92M | 485.8M | 373.53M | 322.86M | 244.01M | 226.88M | 202.68M | 203.97M | 221.19M | 208.1M | 199M | 186.21M | 288.47M | 268.76M | 240.33M |
Other Current Assets | n/a | 78.01M | 9.2M | 13.86M | 11.04M | 7.99M | 9.21M | 52.47M | 8.24M | 8.08M | 12.48M | 13.67M | 90.47M | 86.8M | 6.82M | 11.06M | 9.81M | 95.1M | 5.3M | 89.95M | 92.71M | 120.03M |
Total Current Assets | 2.22B | 2.31B | 2.54B | 2.72B | 2.66B | 2.43B | 3.07B | 2.69B | 2.68B | 2.46B | 2.58B | 2.45B | 2.47B | 2.49B | 2.56B | 2.63B | 2.47B | 2.53B | 2.6B | 2.19B | 2.27B | 2.27B |
Property-Plant & Equipment | 446.84M | 460.3M | 470.62M | 498.1M | 514.9M | 507.65M | 488.65M | 446.69M | 400.2M | 375.57M | 357.11M | 345.82M | 323.6M | 244.88M | 244.99M | 224.04M | 230.29M | 233.23M | 236.69M | 271.91M | 276.2M | 268.18M |
Goodwill & Intangibles | 30.61M | 31.38M | 28.95M | 29.68M | 30.52M | 26.2M | 26.89M | 27.57M | 28.25M | 28.93M | 29.62M | 19.5M | 18.02M | 7.2M | 7.58M | 13.06M | 13.06M | 13.33M | 14.24M | 14.2M | 14.11M | 14.12M |
Total Long-Term Assets | 964.69M | 869.06M | 811.77M | 771.13M | 1.02B | 1.03B | 889.71M | 914.57M | 740.62M | 759.52M | 685.25M | 658.86M | 653.28M | 571.41M | 570.51M | 530.22M | 527.55M | 525.21M | 543.88M | 476.91M | 493.86M | 493.88M |
Total Assets | 3.19B | 3.18B | 3.35B | 3.49B | 3.68B | 3.47B | 3.96B | 3.6B | 3.42B | 3.22B | 3.26B | 3.11B | 3.13B | 3.06B | 3.13B | 3.16B | 3B | 3.06B | 3.15B | 2.66B | 2.76B | 2.77B |
Account Payables | 50.98M | 70.38M | 280.84M | 94.02M | 136.7M | 156.11M | 214.44M | 118.77M | 107.42M | 91.54M | 164.92M | 87.95M | 109.8M | 106.71M | 95.88M | 118.46M | 56.21M | 54.01M | 76.74M | 44.16M | 76.68M | 76.65M |
Deferred Revenue | 110.13M | 116.04M | 443.4M | 485.45M | 395.43M | 44.86M | 130.26M | 127M | 122.04M | 112M | 50.42M | 22.49M | 44.99M | 67.24M | 89.24M | 89.24M | 89.24M | 89.24M | 89.24M | 89.24M | 89.24M | 89.24M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 91.6M | 91.51M | 105.59M | 105.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 16.56M | 266.08M | 176.13M | 206.15M | 210.92M | 166.62M | 200.28M | 183.12M | 171.8M | 145.6M | 178.81M | 154.77M | 278.15M | 318.99M | 134.73M | 136.84M | 116.97M | 292.53M | 110.44M | 210.31M | 227.88M | 175.32M |
Total Current Liabilities | 502.91M | 499.16M | 1.1B | 921.43M | 919.95M | 605.59M | 731.68M | 699.49M | 688.49M | 608.71M | 653.66M | 450.74M | 498.65M | 536.88M | 619.6M | 602.92M | 545.57M | 454.96M | 452.73M | 373.44M | 425.02M | 364.74M |
Long-Term Debt | 847.62M | 838.16M | 828.97M | 1.04B | 1.14B | 1.14B | 1.14B | 1.14B | 1.13B | 1.13B | 1.13B | 1.24B | 1.24B | 1.23B | 1.54B | 1.54B | 1.1B | 1.1B | 1.1B | 1.09B | 1.09B | 1.09B |
Other Long-Term Liabilities | 1.83M | 1.65M | 1.53M | 1.7M | 48.6M | 48.33M | 49.15M | 48.4M | 55.29M | 55.72M | 41.1M | 38.1M | 36.14M | 36.94M | 36.94M | 36.9M | 54.6M | 54.6M | 54.6M | 64.17M | 71.44M | 71.78M |
Total Long-Term Liabilities | 1.16B | 1.17B | 1.11B | 1.25B | 1.4B | 1.72B | 1.7B | 1.68B | 1.66B | 1.65B | 1.75B | 1.89B | 1.89B | 1.81B | 2.12B | 2.12B | 1.72B | 1.74B | 1.77B | 1.82B | 1.85B | 1.87B |
Total Liabilities | 1.66B | 1.67B | 2.21B | 2.17B | 2.32B | 2.32B | 2.44B | 2.38B | 2.35B | 2.26B | 2.41B | 2.35B | 2.38B | 2.35B | 2.74B | 2.73B | 2.27B | 2.2B | 2.22B | 2.19B | 2.27B | 2.23B |
Total Debt | 1.05B | 1.04B | 1.04B | 1.25B | 1.35B | 1.34B | 1.34B | 1.4B | 1.37B | 1.38B | 1.4B | 1.37B | 1.36B | 1.29B | 1.62B | 1.58B | 1.14B | 1.14B | 1.15B | 1.16B | 1.16B | 1.15B |
Book Value | 1.53B | 1.51B | 1.14B | 1.32B | 1.36B | 1.14B | 1.53B | 1.22B | 1.08B | 961.19M | 859.34M | 764.36M | 741.41M | 712.75M | 384.95M | 430.84M | 726.46M | 856.89M | 928.01M | 469.53M | 485.11M | 535.45M |
Book Value Per Share | 14.49 | 12.35 | 10.88 | 13.17 | 12.73 | 11.74 | 14.08 | 12.16 | 10.86 | 9.70 | 8.14 | 8.60 | 8.35 | 8.08 | 4.38 | 4.92 | 8.30 | 9.82 | 11.01 | 5.88 | 6.08 | 6.74 |
Common Stock | 11K | 11K | 11K | 11K | 10K | 10K | 10K | 10K | 10K | 9K | 9K | 9K | 9K | 9K | 9K | 9K | 9K | 9K | 9K | 8K | 8K | 8K |
Retained Earnings | -4.55B | -4.55B | -4.88B | -4.64B | -4.46B | -4.66B | -4.21B | -4.37B | -4.4B | -4.41B | -4.45B | -4.49B | -4.45B | -4.43B | -3.91B | -3.8B | -3.54B | -3.31B | -3.21B | -3.08B | -3.04B | -2.96B |
Comprehensive Income | -565K | -121K | 272K | 220K | -51K | 34K | -218K | 2.25M | -1.03M | -691K | 918K | -638K | -1.06M | -419K | -1.66M | -3.21M | -2.49M | -306K | -20K | -20K | 2K | -3K |
Shareholders Equity | 1.53B | 1.51B | 1.14B | 1.32B | 1.36B | 1.14B | 1.53B | 1.22B | 1.08B | 961.19M | 859.34M | 764.36M | 741.41M | 712.75M | 384.95M | 430.84M | 726.46M | 856.89M | 928.01M | 469.53M | 485.11M | 535.45M |
Total Investments | 362.71M | 291.6M | 139.42M | 247.12M | 324.15M | 391.02M | 388.66M | 1.19B | 1.08B | 1B | 1.25B | 1.2B | 1.04B | 1.04B | 1.05B | 1.07B | 1.09B | 812.94M | 34.89M | 44.6M | 79.29M | 305.95M |
Add to Watchlist
Select watchlists to add or remove SRPT